231 related articles for article (PubMed ID: 9335554)
21. In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: molecular modeling of the mechanism of action of a new antimitotic drug.
Barbier P; Gregoire C; Devred F; Sarrazin M; Peyrot V
Biochemistry; 2001 Nov; 40(45):13510-9. PubMed ID: 11695898
[TBL] [Abstract][Full Text] [Related]
22. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
23. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
24. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
[TBL] [Abstract][Full Text] [Related]
25. Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding.
Gupta KK; Bharne SS; Rathinasamy K; Naik NR; Panda D
FEBS J; 2006 Dec; 273(23):5320-32. PubMed ID: 17069615
[TBL] [Abstract][Full Text] [Related]
26. Biological properties of jatrophane polyesters, new microtubule-interacting agents.
Miglietta A; Gabriel L; Appendino G; Bocca C
Cancer Chemother Pharmacol; 2003 Jan; 51(1):67-74. PubMed ID: 12497208
[TBL] [Abstract][Full Text] [Related]
27. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
Mohan R; Panda D
Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
[TBL] [Abstract][Full Text] [Related]
28. Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly.
Lobert S; Ingram JW; Correia JJ
Cancer Res; 1999 Oct; 59(19):4816-22. PubMed ID: 10519390
[TBL] [Abstract][Full Text] [Related]
29. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.
de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T
Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731
[TBL] [Abstract][Full Text] [Related]
30. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
[TBL] [Abstract][Full Text] [Related]
31. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
32. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG
Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070
[TBL] [Abstract][Full Text] [Related]
33. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
[TBL] [Abstract][Full Text] [Related]
34. Interaction of the antitumor compound cryptophycin-52 with tubulin.
Panda D; Ananthnarayan V; Larson G; Shih C; Jordan MA; Wilson L
Biochemistry; 2000 Nov; 39(46):14121-7. PubMed ID: 11087360
[TBL] [Abstract][Full Text] [Related]
35. Stability of drug-induced tubulin rings by fluorescence correlation spectroscopy.
Boukari H; Nossal R; Sackett DL
Biochemistry; 2003 Feb; 42(5):1292-300. PubMed ID: 12564932
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of inhibition of cell proliferation by Vinca alkaloids.
Jordan MA; Thrower D; Wilson L
Cancer Res; 1991 Apr; 51(8):2212-22. PubMed ID: 2009540
[TBL] [Abstract][Full Text] [Related]
37. Determination of the net exchange rate of tubulin dimer in steady-state microtubules by fluorescence correlation spectroscopy.
Neumann T; Kirschstein SO; Camacho Gomez JA; Kittler L; Unger E
Biol Chem; 2001 Mar; 382(3):387-91. PubMed ID: 11347885
[TBL] [Abstract][Full Text] [Related]
38. Promotion of microtubule assembly in vitro by a novel 35-kDa protein purified from human term placenta.
Hwang BD; Kwak ST; Kweon GR; Lim K
Biochem Biophys Res Commun; 1995 Mar; 208(3):1174-80. PubMed ID: 7702617
[TBL] [Abstract][Full Text] [Related]
39. Anticancer therapy with novel tubulin-interacting drugs.
Kavallaris M; Verrills NM; Hill BT
Drug Resist Updat; 2001 Dec; 4(6):392-401. PubMed ID: 12030786
[TBL] [Abstract][Full Text] [Related]
40. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
Kamath K; Jordan MA
Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]